2-methoxyestradiol - Biology and mechanism of action

Steroids

Volumn 75, Issue 10, 2010, Pages 625-631

  Mueck, A O ^a   Seeger, H ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

2 Methoxyestradiol; Biology; Mechanism of action

Indexed keywords

2 METHOXYESTRADIOL; ADENOVIRUS VECTOR; DOCETAXEL; PROTEIN P53; TAMOXIFEN; 2-METHOXYESTRADIOL; ANTINEOPLASTIC AGENT; ESTRADIOL;

ABSENCE OF SIDE EFFECTS; BREAST CANCER; CELL CULTURE; CLINICAL TRIAL; COLON CARCINOMA; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENTIATION; ENDOMETRIUM CARCINOMA; ESOPHAGUS TUMOR; EYE TUMOR; HUMAN; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CARCINOMA; LOW DRUG DOSE; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; MELANOMA; MUSCLE TUMOR; NERVOUS SYSTEM TUMOR; NONHUMAN; OVARY CARCINOMA; PANCREAS CANCER; PROSTATE CANCER; PROSTATE CARCINOMA; REVIEW; SOLID TUMOR; STOMACH CANCER; UTERINE CERVIX CARCINOMA; VASCULAR TUMOR; ANALOGS AND DERIVATIVES; ANIMAL; BIOLOGICAL MODEL; BREAST NEOPLASMS; CELL LINE; CELL PROLIFERATION; DRUG EFFECTS; FEMALE; MALE; METABOLISM; PROSTATIC NEOPLASMS;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE; CELL PROLIFERATION; ESTRADIOL; FEMALE; HUMANS; MALE; MODELS, BIOLOGICAL; PROSTATIC NEOPLASMS;

ANIMALIA;

EID: 77954311612     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2010.02.016     Document Type: Review

References (86)

1. A.O. Mueck, H. Seeger, and T.H. Lippert Estradiol metabolism and malignant disease Maturitas 43 2002 1 10
2. T.H. Lippert, H. Seeger, and A.O. Mueck Metabolism of endogenous estrogens M. Oettel, E. Schillinger, Estrogens and antiestrogens - handbook of experimental pharmacology 1999 Springer Verlag Berlin 243 271
3. J. Fishman, H.L. Bradlow, and T.F. Gallagher Oxidative metabolism of estradiol J Biol Chem 235 1960 3104 3107
4. C.P. Martucci, and J. Fishman P450 enzymes of estrogen metabolism Pharmacol Ther 57 1993 237 257
5. B.T. Zhu, and A.H. Conney Functional role of estrogen metabolism in target cells: review and perspectives Carcinogenesis 19 1998 1 27
6. 125I- labelled ligand Acta Endocrinol 100 1982 154 160
7. 125I-labelled ligand Acta Endocrinol 103 1983 282 288
8. B.J. Rogerson, and P.K. Eagon A male specific hepatic estrogen binding protein: characteristics and binding properties Arch Biochem Biophys 250 1986 70 85
9. J.F. Dunn, G.R. Merriam, C. Eil, S. Kono, D.L. Loriaux, and B.C. Nisula Testosterone-estradiol binding globulin binds to 2-methoxyestradiol with greater affinity than to testosterone J Clin Endocrinol Metab 51 1980 404 406
10. T. Fotsis, Y. Zhang, M.S. Pepper, H. Adlercreutz, R. Montesano, and P.P. Nawroth The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth Nature 368 1994 237 239
11. N. Klauber, S. Parangi, E. Flynn, E. Hamel, and R.J. D'Amato Inhibition of angiogenesis and breast cancer in mice by microtubule inhibitors 2-methoxyöstradiol and taxol Cancer Res 57 1997 81 86
12. T.L. Yue, X. Wang, C.S. Londen, S. Gupta, K. Pillarisette, and J.L. Gu 2-Methoxyestradiol, an endogenous estrogen metabolite induces apoptosis in endothelial cells and inhibits angiogenesis: possible role for stress-activated protein kinase signaling pathway and Fas expression Mol Pharmacol 51 1997 951 962
13. A. Tsukamoto, Y. Kaneko, T. Yoshida, M. Han, M. Idinose, and S. Kimura 2-Methoxyestradiol, an endogenous metabolite of estrogen, enhances apoptosis and beta-galactosidase expression in vascular endothelial cells Biochem Biophys Res Commun 248 1998 9 12
14. I. Nishigaki, Y. Sasaguri, and K. Yagi Antiproliferative effect of 2-methoxyestradiol on cultured smooth muscle cells from rabbit aorta Atherosclerosis 113 1995 167 170
15. R.K. Dubey, D.G. Giilespie, E.K. Jackson, and P.J. Keller 17 Beta-estradiol, its metabolites, and progesterone inhibit cardiac fibroblast growth Hypertension 31 1998 522 528
16. C. Pico, P. Puigserver, P. Oliver, and A. Palou 2-Methoxyestradiol, an endogenous mammalian metabolite of 17beta-estradiol, inhibits adipocyte proliferation Mol Cell Biochem 189 1998 1 7
17. L.J. Spicer, and J.M. Hammond Catecholestrogens inhibit proliferation and DNA synthesis of porcine granulosa cells in vitro: Comparison with estradiol, 5alpha-dihydrotestosterone, gonadotropins and catecholamines Mol Cell Endocrinol 64 1989 119 126
18. M. Cushman, H.M. He, J.A. Katzenellenbogen, C.M. Lin, and E. Hamel Synthesis, antitubulin and antimitotic activity and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding site J Med Chem 38 1995 2041 2049
19. M. Kataoka, G. Schumacher, R.J. Cristiano, E.N. Atkinson, J.A. Roth, and T. Mukhopadhyay An agent that increases tumor suppressor transgene product coupled with systemic transgene delivery inhibits growth of metastatic lung cancer in vivo Cancer Res 58 1998 4761 4765
20. S.A. Maxwell, J.A. Roth, and T. Mukhopadhyay Analysis of phosphorylated isoforms of the p53 tumor suppressor protein in human lung carcinoma cells undergoing apoptosis Electrophoresis 17 1996 1772 1775
21. T. Mukhopadhyay, and J.A. Roth Induction of apoptosis inhuman lung cancer cells after wild type p53 activation by methoxyestradiol Oncogene 14 1997 379 384
22. T. Mukhopadhyay, and J.A. Roth Superinduction of wild type p53 protein after 2-methoxyestradiol treatment of Ad5p53 transduced cell induces tumor cell apoptosis Oncogene 17 1998 241 246
23. S. Kinuya, A. Kawashima, K. Yokoyama, M. Kudo, Y. Kasahara, and N. Watanabe Anti-angiogenic therapy and radioimmunotherapy in colon cancer xenografts Eur J Nucl Med 28 2001 1306 1312
24. A.M. Carothers, S.A. Hughes, D. Ortega, and M.M. Bertagnolli 2-Methoxyestradiol induces p53-associated apoptosis of colorectal cancer cells Cancer Lett 187 2002 77 86
25. Y. Nakagawa-Yagi, N. Ogane, Y. Inoker, and N. Kitoh The endogenous estrogen metabolite 2-methoxyestradiol induces apoptotic neural cell death in vitro Life Sci 58 1996 1461 1467
26. E. Wassberg Angiostatic treatment of neuroblastoma Ups J Med Sci 104 1999 1 24
27. J. Dobos, J. Tímár, J. Bocsi, Z. Burián, K. Nagy, and G. Barna In vitro and in vivo antitumor effect of 2-methoxyestradiol on human melanoma Int J Cancer 112 2004 771 776
28. R. Ghosh, A.M. Ott, D. Seetharam, T.J. Slaga, and A.P. Kumar Cell cycle block and apoptosis induction in a human melanoma cell line following treatment with 2-methoxyoestradiol: therapeutic implications? Melanoma Res 13 2003 119 127
29. J.M. Day, S.P. Newman, A. Comninos, C. Solomon, A. Purohit, and M.P. Leese The effects of 2-substituted oestrogen sulphamates on the growth of prostate and ovarian cancer cells J Steroid Biochem Mol Biol 84 2003 317 325
30. L.R. Qadan, C.M. Perez-Stable, C. Anderson, G. D'Ippolito, A. Herron, and G.A. Howard 2-Methoxyestradiol induces G2/M arrest and apoptosis in prostate cancer Biochem Biophys Res Commun 285 2001 1259 1266
31. A.P. Kumar, G.E. Garcia, and T.J. Slaga 2-methoxyestradiol blocks cell-cycle progression at G(2)/M phase and inhibits growth of human prostate cancer cells Mol Carcinog 31 2001 111 124
32. S. Bu, A. Blaukat, X. Fu, N.E. Heldin, and M. Landström Mechanisms for 2-methoxyestradiol-induced apoptosis of prostate cancer cells FEBS Lett 531 2002 141 151
33. R.B. Montgomery, M. Bonham, P.S. Nelson, J. Grim, E. Makary, and R. Vessella Estrogen effects on tubulin expression and taxane mediated cytotoxicity in prostate cancer cells Prostate 65 October (2) 2005 141 150
34. P. Davoodpour, and M. Landström 2-Methoxyestradiol-induced apoptosis in prostate cancer cells requires Smad7 J Biol Chem 280 2005 14773 14779
35. J.C. Seegers, M.L. Aveling, C.H. van Aswegen, M. Cross, F. Koch, and W.S. Joubert The cytotoxic effects of estradiol 17β, catecholestrogens and methoxyestradiol on dividing MCF-7 and HeLa cells J Steroid Biochem 32 1989 797 809
36. L. Li, S. Bu, T. Bäckström, M. Landström, U. Ulmsten, and X. Fu Induction of apoptosis and G2/M arrest by 2-methoxyestradiol in human cervical cancer HeLaS3 cells Anticancer Res 24 2004 873 880
37. L. Li, J. Da, M. Landström, U. Ulmsten, and X. Fu Antiproliferative activity and toxicity of 2-methoxyestradiol in cervical cancer xenograft mice Int J Gynecol Cancer 15 2005 301 307
38. A. Joubert, C. Maritz, and F. Joubert Influence of prostaglandin A2 and 2-methoxyestradiol on Bax and Bcl-2 expression levels in cervical carcinoma cells Biomed Res 26 2005 87 90
39. L. Li, N.E. Heldin, J. Grawé, U. Ulmsten, and X. Fu Induction of apoptosis or necrosis in human endometrial carcinoma cells by 2-methoxyestradiol Anticancer Res 24 2004 3983 3990 (Pubitemid 40468697)
40. E. Josefsson, and A. Tarkowski Suppression of type II collagen-induced arthritis by the endogenous estrogen metabolite 2-methoxyestradiol Arthritis Rheum 40 1997 154 163
41. F. Reiser, D. Way, M. Bernas, M. Witte, and C. Witte Inhibition of normal and experimental angiotumor endothelial cell proliferation and cell cycle progression by 2-methoxyestradiol Proc Soc Exp Biol Med 219 1998 211 216
42. A. Joubert, C. Maritz, and F. Joubert Bax/Bcl-2 expression levels of 2-methoxyestradiol-exposed esophageal cancer cells Biomed Res 26 2005 131 134
43. H.L. Lin, T.Y. Liu, C.W. Wu, and C.W. Chi 2-Methoxyestradiol-induced caspase-3 activation and apoptosis occurs through G(2)/M arrest dependent and independent pathways in gastric carcinoma cells Cancer 92 2001 500 509
44. G. Schumacher, M. Kataoka, J.A. Roth, and T. Mukhopadhyay Potent antitumor activity of 2-methoxyestradiol in human pancreatic cancer cell lines Clin Cancer Res 5 1999 493 499
45. E. Ryschich, J. Werner, M.M. Gebhard, E. Klar, and J. Schmidt Angiogenesis inhibition with TNP-470, 2-methoxyestradiol, and paclitaxel in experimental pancreatic carcinoma Pancreas 26 2003 166 172
46. J.C. Seegers, M.L. Lottering, C.J. Grobler, D.H. van Papenclorp, R.C. Habbersett, and Y. Shou The mammalian metabolite, 2-methoxyestradiol, affects p 53 levels and apoptosis induction in transformed cells, but not in normal cells J Steroid Biochem Mol Biol 62 1997 253 267
47. M.L. Lottering, M. de Kock, T.C. Viljoen, C.J. Grobler, and J.C. Seegers 17 beta-estradiol metabolites affect some regulators of the MCF-7 cell cycles Cancer Lett 110 1996 181 186
48. M.L. Lottering, M. Haag, and J.C. Seegers Effects of 17 beta estradiol metabolites on cell cycle events in MCF-7 cells Cancer Res 52 1992 5926 5932
49. M.N. Zoubine, A.P. Weston, D.C. Johnson, D.R. Campbell, and S.K. Banerjee 2-methoxyestradiol-induced growth suppression and lethality in estrogen-responsive MCF-7 cells may be mediated by down regulation of p34cdc2 and cyclin B1 expression Int J Oncol 15 1999 639 646
50. G.P. Amorino, M.L. Freeman, and H. Choy Enhancement of radiation effects in vitro by the estrogen metabolite 2-methoxyestradiol Radiat Res 153 2000 384 391
51. C. Lippert, H. Seeger, and A.O. Mueck The effect of endogenous estradiol metabolites on the proliferation of human breast cancer cells Life Sci 72 2003 877 883 (Pubitemid 35454133)
52. Z.J. Liu, W.J. Lee, and B.T. Zhu Selective insensitivity of ZR-75-1 human breast cancer cells to 2-methoxyestradiol: evidence for type II 17beta-hydroxysteroid dehydrogenase as the underlying cause Cancer Res 65 2005 5802 5811
53. T.E. Sutherland, M. Schuliga, T. Harris, B.L. Eckhardt, R.L. Anderson, and L. Quan 2-Methoxyestradiol is an estrogen receptor agonist that supports tumor growth in murine xenograft models of breast cancer Clin Cancer Res 11 2005 1722 1732
54. G.Z. Han, Z.J. Liu, K. Shimoi, and B.T. Zhu Synergism between the anticancer actions of 2-methoxyestradiol and microtubule-disrupting agents in human breast cancer Cancer Res 65 January (2) 2005 387 393
55. J.S. Lewis, T.J. Thomas, R.G. Pestell, C. Albanese, M.A. Gallo, and T. Thomas Differential effects of 16alpha-hydroxyestrone and 2-methoxyestradiol on cyclin D1 involving the transcription factor ATF-2 in MCF-7 breast cancer cells J Mol Endocrinol 34 2005 91 105
56. G. Schumacher, J.M. Langrehr, and D. Baumund 2-Methoxyestradiol has growth inhibitory effect alone and in combination with conventional chemotherapy on human pancreatic cancer cells and inhibits growth of multi-drug resistant pancreatic cancer cells Proc Am Assoc Cancer Res 44 2003 1304 1305
57. A.O. Mueck, H. Seeger, and J. Huober Chemotherapy of breast cancer-additive anticancerogenic effect by 2-methoxyestradiol? Life Sci. 75 2004 1205 1210
58. A.O. Mueck, H. Seeger, D. Wallwiener, and J. Huober Is the combination with 2-methoxy-estradiol able to reduce the dosages of chemotherapeutics in treatment on human ovary cancer? Eur J Gyncol Oncol 25 2004 699 701
59. T.H. Lippert, H. Adlercreutz, M. Berger, H. Seeger, W. Elger, and A.O. Mueck Effect of 2-methoxyestradiol on the growth of MNU-induced rat mammary carcinoma J Steroid Biochem Mol Biol 84 2003 51 56
60. J.B. Huober, S. Nakamura, R. Meyn, J.A. Roth, and T. Mukhopadhyay Oral administration of an estrogen metabolite-induced potentiation of radiation antitumor effects in presence of wild-type p53 in non-small-cell lung cancer Int J Radiat Oncol Biol Phys 48 2000 1127 1137
61. C. Sweeney, G. Liu, C. Yiannoutsos, J. Kolesar, D. Horvath, and M.J. Staab A phase II multicenter, randomized, double-blind, safety trial assessing the pharmacokinetics, pharmacodynamics, and efficacy of oral 2-methoxyestradiol capsules in hormone-refractory prostate cancer Clin Cancer Res 11 2005 6625 6633
62. W.L. Dahut, N.J. Lakhani, J.L. Gulley, P.M. Arlen, E.C. Kohn, and H. Kotz Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors Cancer Biol Ther 5 2006 22 27
63. J. James, D.J. Murry, A.M. Treston, A.M. Storniolo, G.W. Sledge, and C. Sidor Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer Invest New Drugs 25 2007 41 48
64. A.J. Tevaarwerk, K.D. Holen, D.B. Alberti, C. Sidor, J. Arnott, and C. Quon Phase I trial of 2-methoxyestradiol NanoCrystal dispersion in advanced solid malignancies Clin Cancer Res 15 2009 1460 1465
65. D. Matei, J. Schilder, G. Sutton, S. Perkins, T. Breen, and C. Quon Activity of 2-methoxyestradiol (Panzem((R)) NCD) in advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis: A Hoosier Oncology Group trial Gynecol Oncol 2009 [Epub ahead of print]
66. S.L. Mooberry New insights into 2-methoxyestradiol, a promising antiangiogenic and antitumor agent Curr Opin Oncol 15 2003 425 430
67. N.J. Mabjeesh, D. Escuin, T.M. LaVallee, V.S. Pribluda, G.M. Swartz, and M.S. Johnson 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF Cancer Cell 3 2003 363 375
68. T.L. Tinley, R.M. Leal, D.A. Randall-Hlubek, J.W. Cessac, L.R. Wilkens, and P.N. Rao Novel 2-methoxyestradiol analogues with antitumor activity Cancer Res 63 2003 1538 1549
69. K. Shimada, M. Nakamura, E. Ishida, M. Kishi, and N. Konishi Roles of p38- and c-jun NH2-terminal kinase-mediated pathways in 2-methoxyestradiol- induced p53 induction and apoptosis Carcinogenesis 24 2003 1067 1075
70. A. Basu, and S. Haldar Identification of a novel Bcl-xL phosphorylation site regulating the sensitivity of taxol- or 2-methoxyestradiol-induced apoptosis FEBS Lett 538 2003 41 47
71. D.E. Van Orden, S.P. Ford, and D.B. Farley Induction of uterine arterial vasodilation by estradiol and catechol estradiols Proc Soc Gynecol Invest 30 1983 Abstr. 58
72. S.P. Ford, D.E. Van Orden, and C.B. Farley Effect of cycloheximide on catechol estrogen induced uterine hyperemia Proc Soc Gyn Invest 33 1986 Abstr. 378
73. 2+ uptake of uterine arterial smooth muscle cells through potential-sensitive channels Biol Reprod 36 1987 361 368
74. 2+ channels in altering uterine blood flow during the estrous cycle and early pregnancy in gilts Biol Reprod 36 1987 369 375
75. H. Heinle, N. Orth, E. Neeser, and T.H. Lippert Effects of 17β-estradiol and its catechol metabolites on the contractility of human uterine artery: in vitro experiments T.H. Lippert, A.O. Mueck, J. Ginsburg, Sex steroids and the cardiovascular system 1997 Pathenon Publishing Group London 75 83
76. N. Orth, E. Neeser, H. Seeger, W. Schneider, T.H. Lippert, and F. Lang Calcium antagonistic effect of estrogen and estrogen metabolites in smooth muscle: evidence from contraction measurements and intracellular calcium imaging Pflügers Arch Eur J Physiol 435 Suppl. 1998 R204
77. R. Ross The pathogenesis of atherosclerosis - an update N Engl J Med 314 1986 488 500
78. H. Seeger, A.O. Mueck, and T.H. Lippert The antiproliferative effect of 17β-estradiol metabolites on human coronary artery smooth muscle cells Med Sci Res 26 1998 481 482
79. R.K. Dubey, D.G. Gillespie, L.C. Zacharia, M. Rosselli, K.R. Korzekwa, and J. Fingerle Methoxyestradiols mediate the antimitogenic effects of estradiol on vascular smooth muscle cells via estrogen receptor-independent mechanisms Biochem Biophys Res Commun 278 2000 27 33
80. R.K. Dubey, E.K. Jackson, P.J. Keller, B. Imthurn, and M. Rosselli Estradiol metabolites inhibit endothelin synthesis by an estrogen receptor-independent mechanism Hypertension 37 2001 640 644
81. S.P. Tofovic, E.M. Salah, R.K. Dubey, M.F. Melhem, and E.K. Jackson Estradiol metabolites attenuate renal and cardiovascular injury induced by chronic nitric oxide synthase inhibition J Cardiovasc Pharmacol 46 2005 25 35
82. Y. Gui, X.L. Zheng, J. Zheng, and M.P. Walsh Inhibition of rat aortic smooth muscle contraction by 2-methoxyestradiol Am J Physiol Heart Circ Physiol 295 2008 H1935 H1942
83. T.L. Bush, E. Barrett-Connor, L.D. Cowan, M.H. Criqui, R.B. Wallace, and C.M. Suchindran Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study Circulation 75 1987 1102 1109
84. D.F. Liu, and K.A. Bachmann An investigation of the relationship between estrogen, estrogen metabolites and blood cholesterol levels in ovariectomized rats J Pharmacol Exp Ther 286 1998 561 568
85. H. Seeger, A.O. Mueck, and T.H. Lippert The inhibitory effect of endogenous estrogen metabolites on copper-mediated in vitro oxidation of LDL Int J Clin Pharm Ther 36 1998 383 385
86. K. Kanasaki, K. Palmsten, H. Sugimoto, S. Ahmad, Y. Hamano, and L. Xie Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia Nature 453 2008 1117 1121